SureTrader
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

NMUS RSS Feed
Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: Southern Gal, MERCURIAL, MADDSTACKER, MrCheap, CopperHunter
Search This Board: 
Last Post: 2/18/2018 6:50:34 PM - Followers: 143 - Board type: Free - Posts Today: 0


 

 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:  http://www.nemusbioscience.com/home.html

Filings and disclosure with Level 2 quotes:  http://www.otcmarkets.com/stock/NMUS/quote

Contact:

(949) 396-0330
E-MAIL: BRIAN@NEMUSBIO.COM
600 ANTON BLVD, SUITE 1100, COSTA MESA, CA 92626


 

Nemus Bioscience (NMUS) Presentation (47 minutes):  
https://www.youtube.com/watch?v=tYV2PEaj6os

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016: 
http://s2.q4cdn.com/753474459/files/doc_presentations/2016/Rodman-Conf-September-2016_FINAL.pdf



 


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  
 

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -


Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy


Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)

 

Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model

 

Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.


NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 


CANNAINVESTOR Magazine Top 20 Cannabis Stocks 

 

NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 

 

NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 

 

NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 

 

Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 

 

NMUS Security Details

Share Structure - as of Feb 1, 2017
Source: otcmarkets.com

Authorized Shares: 236,000,000
Outstanding Shares: 
22,438,163
      - Restricted  13,494,621
    - Unrestricted   8,943,542

           - Float   5,005,713 a/o Mar 23, 2016 
   Par Value 0.001


Transfer Agent: Clear Trust, LLC

SureTrader
NMUS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 02/13/2018 04:14:21 PM
NMUS News: Current Report Filing (8-k) 02/13/2018 04:09:08 PM
NMUS News: Statement of Beneficial Ownership (sc 13d) 01/30/2018 06:08:58 AM
NMUS News: Initial Statement of Beneficial Ownership (3) 01/29/2018 05:42:46 PM
NMUS News: Small Company Offering and Sale of Securities Without Registration (d) 01/25/2018 12:45:07 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3633  Sticky Note NMUS DD TheMonolith 01/21/18 10:38:25 AM
#3447  Sticky Note Nemus Secures Emerald Health as Strategic Majority Investor MERCURIAL 01/19/18 01:32:50 PM
#3204  Sticky Note $NMUS PIPELINE MERCURIAL 01/09/18 09:11:53 AM
#4466   Big you are right 100 %. drew5 02/18/18 06:50:34 PM
#4465   I agree, accept for one thing: Att_for_life 02/18/18 04:47:27 PM
#4464   As much as Trump is hated by many bigmoneyyyyyyyyy 02/18/18 01:23:47 PM
#4463   Ya that's nothing new. And the %70 of BrophInvest 02/17/18 08:37:11 PM
#4462   Old news... Att_for_life 02/17/18 05:47:13 PM
#4461   Lets go! $NMUS MrCheap 02/17/18 11:18:23 AM
#4460   Funny US Government says ZERO medicinal benefits from Blazeaglory 02/17/18 02:45:03 AM
#4459   Wow Emerald is chomping at the bit here...love The Rainmaker 02/16/18 08:49:05 PM
#4458   Great news full steam ahead !! MADDSTACKER 02/16/18 08:23:45 PM
#4457   Awesome news! $NMUS MERCURIAL 02/16/18 08:09:51 PM
#4456   Excellent news. $NMUS is a gem at these levels BrophInvest 02/16/18 06:56:29 PM
#4455   Nemus full of great news today, the management GM26 02/16/18 06:26:10 PM
#4454   Love to see the deal closed and so frozenspokes 02/16/18 06:20:05 PM
#4453   News: $NMUS Emerald Health, Strategic Majority Investor in Nemus GM26 02/16/18 05:54:04 PM
#4452   hmmm... synergy... Lavatime 02/16/18 12:34:18 PM
#4451   No kidding. MM's are playing games here. Big BrophInvest 02/16/18 11:20:06 AM
#4450   Who's yeti? Att_for_life 02/16/18 01:10:34 AM
#4449   Yeti gonna get caught https://www.google.com/amp/s/www.nbcnewyork.com/news/local TheMonolith 02/15/18 06:45:21 PM
#4448   Crazy MM manipulation... Att_for_life 02/15/18 04:29:01 PM
#4447   Agreed easy buy and hold :) nice when MADDSTACKER 02/15/18 01:57:55 PM
#4446   Nice, they're(Emerald BOD) like kids out there(applying scientific TheMonolith 02/15/18 12:03:57 PM
#4445   Thanks MADDSTACKER, I believe it was you that zenvesting 02/15/18 11:55:29 AM
#4444   Fantastic news! The picture is becoming clearer with MERCURIAL 02/15/18 11:53:54 AM
#4443   Nice article MADDSTACKER 02/15/18 11:28:00 AM
#4442   Fox Business, Emerald article: Marijuana and Blockchain: A Quintessence 02/15/18 11:23:55 AM
#4441   Emerald news . https://www.dailymarijuanaobserver.com/single-post/2018/02/15/Eme MADDSTACKER 02/15/18 10:50:37 AM
#4440   Some nice sized bids out there CPTMatt 02/15/18 09:50:37 AM
#4439   Still need to try and break through 40 Royals2015 02/15/18 09:39:28 AM
#4438   Yes sir! Looking good. :) MERCURIAL 02/15/18 09:38:22 AM
#4437   NMUS trading well the morning! Up 15%. Quintessence 02/15/18 09:37:19 AM
#4436   Morning $NMUS fans. One foot in front of MERCURIAL 02/15/18 07:48:19 AM
#4435   That’s the ticket :)that’s why I bought !!!!! MADDSTACKER 02/15/18 07:11:55 AM
#4434   I'm an emeraldhead. Have made almost 6 figures TheMonolith 02/14/18 10:30:01 PM
#4433   Your point is well made but I don't Jascom 02/14/18 10:22:31 PM
#4432   Emerald has rolled up their sleeves and has The Rainmaker 02/14/18 10:03:26 PM
#4431   I agree this is a buy hold for drew5 02/14/18 09:57:49 PM
#4430   Everybody on this board is smarter than I Jascom 02/14/18 09:43:50 PM
#4429   If schedule 1 is removed, Att_for_life 02/14/18 04:12:29 PM
#4428   Thank you for more succinctly making the point. TheMonolith 02/14/18 03:22:27 PM
#4427   Their relationship is more analogous of siblings, not zenvesting 02/14/18 03:16:26 PM
#4426   Emerald Health Sciences bought a little over 58% zenvesting 02/14/18 03:11:43 PM
#4425   Completely agree. The presentation yesterday definitely indicated they TheMonolith 02/14/18 03:09:37 PM
#4424   Well, I'm glad... Att_for_life 02/14/18 03:08:14 PM
#4423   I have seen many drug development deals where The Rainmaker 02/14/18 03:07:02 PM
#4422   I read that too, but I think the TheMonolith 02/14/18 03:06:36 PM
#4421   The TSX has decided to back off, Att_for_life 02/14/18 03:05:55 PM
#4420   Because when you are a kid who plans The Rainmaker 02/14/18 03:02:22 PM
#4419   I'm under the impression that NMUS will have TheMonolith 02/14/18 03:01:23 PM
#4418   A well funded Emerald has the potential to The Rainmaker 02/14/18 02:58:01 PM
#4417   I think the parent company saw value and TheMonolith 02/14/18 02:54:14 PM
PostSubject